Pages that link to "Q40047862"
The following pages link to Which Dengue Vaccine Approach Is the Most Promising, and Should We Be Concerned about Enhanced Disease after Vaccination? The Risks of Incomplete Immunity to Dengue Virus Revealed by Vaccination (Q40047862):
Displaying 7 items.
- Biomimetic inorganic camouflage circumvents antibody-dependent enhancement of infection. (Q53427852) (← links)
- Dengue envelope-based 'four-in-one' virus-like particles produced using Pichia pastoris induce enhancement-lacking, domain III-directed tetravalent neutralising antibodies in mice. (Q55244392) (← links)
- A Combination of Two Human Monoclonal Antibodies Prevents Zika Virus Escape Mutations in Non-human Primates (Q58606057) (← links)
- Chikungunya as a paradigm for emerging viral diseases: Evaluating disease impact and hurdles to vaccine development (Q61814703) (← links)
- Dengue-specific CD8+ T cell subsets display specialized transcriptomic and TCR profiles (Q66680670) (← links)
- Immunogenicity of a novel tetravalent dengue envelope protein domain III-based antigen in mice (Q90623173) (← links)
- Does structurally-mature dengue virion matter in vaccine preparation in post-Dengvaxia era? (Q91957254) (← links)